These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

945 related articles for article (PubMed ID: 27836008)

  • 1. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
    Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
    BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus X protein stimulates high mobility group box 1 secretion and enhances hepatocellular carcinoma metastasis.
    Chen S; Dong Z; Yang P; Wang X; Jin G; Yu H; Chen L; Li L; Tang L; Bai S; Yan H; Shen F; Cong W; Wen W; Wang H
    Cancer Lett; 2017 May; 394():22-32. PubMed ID: 28216372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma.
    Li L; Xu L; Yan J; Zhen ZJ; Ji Y; Liu CQ; Lau WY; Zheng L; Xu J
    J Exp Clin Cancer Res; 2015 Oct; 34():129. PubMed ID: 26503598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
    Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
    J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma.
    Dai XM; Huang T; Yang SL; Zheng XM; Chen GG; Zhang T
    Dis Markers; 2017; 2017():8495326. PubMed ID: 28572700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection.
    Li YW; Qiu SJ; Fan J; Zhou J; Gao Q; Xiao YS; Xu YF
    J Hepatol; 2011 Mar; 54(3):497-505. PubMed ID: 21112656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral and peritumoral expression of CD68 and CD206 in hepatocellular carcinoma and their prognostic value.
    Ren CX; Leng RX; Fan YG; Pan HF; Li BZ; Wu CH; Wu Q; Wang NN; Xiong QR; Geng XP; Ye DQ
    Oncol Rep; 2017 Aug; 38(2):886-898. PubMed ID: 28656201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of PUMA expression in patients with HBV-related hepatocellular carcinoma.
    Peng SL; Yao DB; Zhao Y; Xu F; Jia CJ; Xu YQ; Dai CL
    Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):38-44. PubMed ID: 25635973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma.
    Li L; Yan J; Xu J; Liu CQ; Zhen ZJ; Chen HW; Ji Y; Wu ZP; Hu JY; Zheng L; Lau WY
    PLoS One; 2014; 9(10):e110064. PubMed ID: 25303284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
    Lee S; Rhim H; Kim YS; Kang TW; Song KD
    Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritumoral ductular reaction: a poor postoperative prognostic factor for hepatocellular carcinoma.
    Xu M; Xie F; Qian G; Jing Y; Zhang S; Gao L; Zheng T; Wu M; Yang J; Wei L
    BMC Cancer; 2014 Feb; 14():65. PubMed ID: 24495509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy.
    Liu F; Zhang Y; Peng Z; Gao H; Xu L; Chen M
    J Transl Med; 2012 Jul; 10():135. PubMed ID: 22747650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguished prognosis after hepatectomy of HBV-related hepatocellular carcinoma with or without cirrhosis: a long-term follow-up analysis.
    Yang SL; Liu LP; Sun YF; Yang XR; Fan J; Ren JW; Chen GG; Lai PB
    J Gastroenterol; 2016 Jul; 51(7):722-32. PubMed ID: 26607653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus (HBV) receptors: Deficiency in tumor results in scant HBV infection and overexpression in peritumor leads to higher recurrence risk.
    Jing YY; Liu WT; Guo SW; Ye F; Fan QM; Yu GF; Yu DD; Gao L; Sun K; Han ZP; Li R; Yang Y; Zhao QD; Wu MC; Wang HY; Wei LX
    Oncotarget; 2015 Dec; 6(40):42952-62. PubMed ID: 26515593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between androgen receptor expression and hepatitis B virus X protein and its clinical significance in hepatocellular carcinoma].
    Gu DH; Zhu YZ; Wang X; Bai ZC; Ping JL; Chen Q; Zhu R
    Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):282-7. PubMed ID: 23985257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased Expression of ZWINT is Associated With Poor Prognosis in Patients With HCC After Surgery.
    Yang XY; Wu B; Ma SL; Yin L; Wu MC; Li AJ
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818794190. PubMed ID: 30198401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.